Resistant kawasaki disease in an infant causing giant coronary aneurysms with thrombosis

A. Anass, Hasbaoui Brahim, S. Salah, Yajouri Abdelhakim, A. Rachid, Hassani Amale, A. Aomar, Faid Soumia
{"title":"Resistant kawasaki disease in an infant causing giant coronary aneurysms with thrombosis","authors":"A. Anass, Hasbaoui Brahim, S. Salah, Yajouri Abdelhakim, A. Rachid, Hassani Amale, A. Aomar, Faid Soumia","doi":"10.15761/JCCR.1000158","DOIUrl":null,"url":null,"abstract":"A 13 month-old boy male infant admitted for fever, generalized polymorphous exanthema, hyperemic conjunctivae, and diarrhea. The onset of the disease was approximately 2 weeks before the admission with a generalized polymorphous exanthema for which he received antihistaminic treatment, but after 7 days he associated fever, hyperemic conjunctivae, and diarrhea being admitted in the regional hospital. The fever persisted despite the antibiotic and symptomatic treatment, and therefore he was transferred in our hospital. The clinical exam at the time of admission revealed influenced general status, generalized polymorphous exanthema, hyperemic pharynx, bilateral conjunctivitis, and approximately five diarrheic stools per day. The laboratory tests revealed leukocytosis (27,050/mL), with neutrophilia (19,900/mL), anemia (Hb 6.9 g/dL, Htc 19.7%, MEV 68.6 fL, MEH 24 pg), thrombocytosis (1,111,000/ mL), elevated inflammatory biomarkers (CRP An Abstract Giant coronary artery aneurysms that occur in 0.5 to 1% of patients with Kawasaki disease can be fatal if associated with thrombosis. Some patients may show persistent inflammation and fever despite treatment with repeated doses of intravenous immunoglobulin (IVIG), steroids, and aspirin. This report describes an infant boy with resistant Kawasaki disease who presented with extensive coronary artery involvement and coronary thrombosis. His inflammation was not controlled with multiple doses of IVIG, parenteral and oral steroids, or high-dose aspirin, and he finally needed infliximab, a monoclonal antibody against tumor necrosis factor alpha.","PeriodicalId":73637,"journal":{"name":"Journal of cardiology case reports","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2020-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of cardiology case reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/JCCR.1000158","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A 13 month-old boy male infant admitted for fever, generalized polymorphous exanthema, hyperemic conjunctivae, and diarrhea. The onset of the disease was approximately 2 weeks before the admission with a generalized polymorphous exanthema for which he received antihistaminic treatment, but after 7 days he associated fever, hyperemic conjunctivae, and diarrhea being admitted in the regional hospital. The fever persisted despite the antibiotic and symptomatic treatment, and therefore he was transferred in our hospital. The clinical exam at the time of admission revealed influenced general status, generalized polymorphous exanthema, hyperemic pharynx, bilateral conjunctivitis, and approximately five diarrheic stools per day. The laboratory tests revealed leukocytosis (27,050/mL), with neutrophilia (19,900/mL), anemia (Hb 6.9 g/dL, Htc 19.7%, MEV 68.6 fL, MEH 24 pg), thrombocytosis (1,111,000/ mL), elevated inflammatory biomarkers (CRP An Abstract Giant coronary artery aneurysms that occur in 0.5 to 1% of patients with Kawasaki disease can be fatal if associated with thrombosis. Some patients may show persistent inflammation and fever despite treatment with repeated doses of intravenous immunoglobulin (IVIG), steroids, and aspirin. This report describes an infant boy with resistant Kawasaki disease who presented with extensive coronary artery involvement and coronary thrombosis. His inflammation was not controlled with multiple doses of IVIG, parenteral and oral steroids, or high-dose aspirin, and he finally needed infliximab, a monoclonal antibody against tumor necrosis factor alpha.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
一例婴儿的耐药性川崎病导致巨大冠状动脉瘤伴血栓形成
一例13个月大的男婴因发热、全身性多形疹、结膜充血和腹泻入院。患者在入院前约2周发病,伴有广泛性多形性皮疹,并接受了抗组胺药治疗,但7天后,患者出现发热、结膜充血和腹泻,住进了地区医院。尽管抗生素和对症治疗,发烧仍持续,因此他被转移到我们医院。入院时的临床检查显示全身状态受影响,全身性多形样疹,咽部充血,双侧结膜炎,每天约5次腹泻。实验室检查显示白细胞增多(27,050/mL),中性粒细胞增多(19,900/mL),贫血(Hb 6.9 g/dL, Htc 19.7%, MEV 68.6 fL, MEH 24 pg),血小板增多(1,111,000/ mL),炎症生物标志物(CRP)升高。在0.5%至1%的川崎病患者中发生的巨大冠状动脉动脉瘤如果与血栓形成相关,可能是致命的。尽管多次静脉注射免疫球蛋白(IVIG)、类固醇和阿司匹林,一些患者仍可能出现持续的炎症和发烧。本报告描述了一个顽固性川崎病的男婴,他表现出广泛的冠状动脉受累和冠状动脉血栓形成。多剂量IVIG、肠外和口服类固醇或大剂量阿司匹林都无法控制他的炎症,最后他需要英夫利昔单抗,一种抗肿瘤坏死因子α的单克隆抗体。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Atrapamiento del tendón tibial posterior en luxofractura irreductible abierta de tobillo: reporte de un caso. Remisión sintomática en una paciente con artritis reumatoidea tratada con Terapia Neural. Reporte de caso Colangitis esclerosante secundaria tras COVID-19 grave. Reporte de caso El sistema inmunológico, un aliado impredecible Tratamiento de una úlcera flebostática en miembro inferior con plasma rico en plaquetas activado con ozono-cloruro de calcio y membranas de fibrina. Reporte de caso
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1